Skip to content

A clinical study to see the result of Arjuna,Manjistha and Vasa patra churna lepa with Madhu Facial Hyperpigmentation

A Pharmaco-clinical study to evaluate the effectiveness of Arjuna[Terminalia arjuna Roxb],Manjistha[Rubia cardifolia Linn] and Vasa[Adhatoda vasica Nees] patra churna lepa with Madhu in the management of Vyanga w.s.r. to melasma - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096162
Enrollment
60
Registered
2025-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Sponsors

State Ayurvedic College and Hospital,Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both acute and chronic cases of vyanga with special reference to mealasma will be treated .patient willing to participate in above mentioned trial .Diagnosed with classical features of vyanga as described in samhitas.

Exclusion criteria

Exclusion criteria: Age group less than 30 years and more than 50 years Hyper pigmentation caused due to any known cases of systemic diseases like Addison disease,Cushing syndrome. People suffering from chronic liver and renal disorders. Hyper pigmentation caused by tumors like malignant melanoma Pregnant women patients who are on chemotherapy or radiotherapy will be excluded.

Design outcomes

Primary

MeasureTime frame
Essential criteria 1 Shyavavarna[grey brown] 2 Niruja[painless] 3 Tanu[non elevated] 4 Mandal[patches with irregular border] Non Essential criteria 1 Familial history 2 Sun exposure Objective criteria 1 Area of lesion 2 Visibility of pigmentationTimepoint: Tthe follow up conducted during study period for once in 15 days.After completion of trial of two months ,the follow up without drug after 15th day

Secondary

MeasureTime frame
CBC LFT,KFT Bloodsugar[random/fasting/pp/HbA1c] Lipid profile Thyroid profile Timepoint: the follow up conducted during study period for once in 15 days After completion of trial of two months ,the follow up without drug after 15th day

Countries

India

Contacts

Public ContactDr Ramanand

State Ayurvedic College and Hospital Lucknow

dr.ramanand72@gmail.com9045699482

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026